Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$203.52 - $273.43 $1.22 Million - $1.64 Million
-5,989 Reduced 1.62%
364,614 $98.8 Million
Q4 2023

Feb 09, 2024

SELL
$164.52 - $238.84 $2.57 Million - $3.73 Million
-15,615 Reduced 4.04%
370,603 $87.6 Million
Q3 2023

Nov 09, 2023

SELL
$194.44 - $217.61 $1.56 Million - $1.75 Million
-8,041 Reduced 2.04%
386,218 $75.7 Million
Q2 2023

Aug 10, 2023

SELL
$183.71 - $210.25 $55.4 Million - $63.4 Million
-301,716 Reduced 43.35%
394,259 $82.9 Million
Q1 2023

May 12, 2023

SELL
$191.89 - $259.92 $2.7 Million - $3.65 Million
-14,045 Reduced 1.98%
695,975 $140 Million
Q4 2022

Feb 09, 2023

SELL
$197.11 - $250.07 $3.46 Million - $4.39 Million
-17,536 Reduced 2.41%
710,020 $155 Million
Q3 2022

Nov 09, 2022

SELL
$182.44 - $250.54 $50.7 Million - $69.6 Million
-277,643 Reduced 27.62%
727,556 $143 Million
Q2 2022

Aug 10, 2022

SELL
$204.13 - $302.4 $6.28 Million - $9.3 Million
-30,769 Reduced 2.97%
1,005,199 $215 Million
Q1 2022

May 11, 2022

SELL
$255.51 - $362.11 $10.3 Million - $14.6 Million
-40,282 Reduced 3.74%
1,035,968 $294 Million
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $47 Million - $60 Million
133,654 Added 14.18%
1,076,250 $406 Million
Q3 2021

Nov 10, 2021

SELL
$372.64 - $458.3 $13.4 Million - $16.4 Million
-35,882 Reduced 3.67%
942,596 $389 Million
Q2 2021

Aug 12, 2021

SELL
$294.17 - $371.65 $4.03 Million - $5.09 Million
-13,702 Reduced 1.38%
978,478 $362 Million
Q1 2021

May 13, 2021

BUY
$249.67 - $299.48 $215 Million - $258 Million
861,234 Added 657.7%
992,180 $288 Million
Q4 2020

Feb 09, 2021

SELL
$222.0 - $252.62 $7.74 Million - $8.81 Million
-34,866 Reduced 21.03%
130,946 $32.7 Million
Q3 2020

Nov 06, 2020

BUY
$175.56 - $226.45 $29.1 Million - $37.5 Million
165,812 New
165,812 $37.5 Million
Q3 2018

Nov 13, 2018

SELL
$112.11 - $134.54 $187 Million - $225 Million
-1,671,909 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$102.37 - $117.25 $3.75 Million - $4.29 Million
-36,614 Reduced 2.14%
1,671,909 $188 Million
Q1 2018

May 14, 2018

BUY
$98.19 - $115.2 $29.6 Million - $34.8 Million
301,779 Added 21.45%
1,708,523 $182 Million
Q4 2017

Feb 14, 2018

BUY
$100.43 - $118.09 $137 Million - $161 Million
1,361,626 Added 3017.92%
1,406,744 $154 Million
Q3 2017

Nov 13, 2017

BUY
$96.72 - $109.26 $4.36 Million - $4.93 Million
45,118
45,118 $4.87 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $7.88B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track William Blair Investment Management, LLC Portfolio

Follow William Blair Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on William Blair Investment Management, LLC with notifications on news.